- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sprint Bioscience AB (SPRINT)
Assess today's live Sprint Bioscience AB (SPRINT) share price, performance and insights using our live Stockholm: SPRINT stock exchange data.
Analyse the historical data and Sprint Bioscience AB share price performance charts on this page. Our technical summary section provides analysis on Sprint Bioscience AB share price buy/sell indicators using real-time data (or discuss the Sprint Bioscience AB (SPRINT) stock price today with other investors in the Sprint Bioscience AB ST share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ST SPRINT share price (ISIN: SE0006343745) to enhance your trading decisions with our free investment tools and resources.
What Is the Sprint Bioscience AB Share Price Today?
The Sprint Bioscience AB share price today is 1.895.
What Is the Stock Symbol for Sprint Bioscience AB
The stock symbol (or 'ticker') for Sprint Bioscience AB is "SPRINT."
What Stock Exchange Does Sprint Bioscience AB Trade On?
Sprint Bioscience AB is listed and trades on the Stockholm stock exchange.
Is Sprint Bioscience AB a Good Stock to Buy?
Determining whether Sprint Bioscience AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Sprint Bioscience AB share price performance charts on this page. Our technical summary section provides analysis on Sprint Bioscience AB share price buy/sell indicators using real-time data (or discuss the Sprint Bioscience AB (SPRINT) stock price today with other investors in the Sprint Bioscience AB ST share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current ST SPRINT share price (ISIN: SE0006343745) to enhance your trading decisions with our free investment tools and resources.
What Is the Sprint Bioscience AB Share Price Today?
The Sprint Bioscience AB share price today is 1.895.
What Is the Stock Symbol for Sprint Bioscience AB
The stock symbol (or 'ticker') for Sprint Bioscience AB is "SPRINT."
What Stock Exchange Does Sprint Bioscience AB Trade On?
Sprint Bioscience AB is listed and trades on the Stockholm stock exchange.
Is Sprint Bioscience AB a Good Stock to Buy?
Determining whether Sprint Bioscience AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Stockholm
Currency in SEK
1.895
+0.010(+0.53%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.755
1.895
52 wk Range
0.360
2.350
SPRINT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.7551.895
52 wk Range
0.3602.350
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
SPRINT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Sprint Bioscience AB (publ), a pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden. The company develops VPS34, a drug candidate for the treatment of various types of cancer by using immunotherapies; TREX1, a drug candidate for the treatment of immuno-oncology, radiotherapy and chemotherapy in the treatment of cancer. It also develops PETRA01, a drug candidate for the treatment of cancer. In addition, the company focuses on research of products for the treatment of tumor metabolism and nash. It has a research collaboration with the Experimental Drug Development Centre for expansion of metabolic dysfunction-associated steatohepatitis programme into inflammatory diseases. The company was incorporated in 2009 and is based in Huddinge, Sweden.
Compare SPRINT to Peers and Sector
Metrics to compare | SPRINT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSPRINTPeersSector | |
|---|---|---|---|---|
P/E Ratio | 2.2x | −3.1x | −0.5x | |
PEG Ratio | 0.00 | −0.09 | 0.00 | |
Price/Book | 1.7x | 2.7x | 2.6x | |
Price / LTM Sales | 1.2x | 4.7x | 3.2x | |
Upside (Analyst Target) | 75.1% | 109.7% | 51.2% | |
Fair Value Upside | Unlock | 17.0% | 7.3% | Unlock |
Earnings
Latest Release
Feb 11, 2026
EPS / Forecast
1.06 / --
Revenue / Forecast
133.91M / --
People Also Watch
FAQ
What Is the Sprint Bioscience AB (SPRINT) Share Price Today?
The Sprint Bioscience AB stock price today is 1.895 SEK.
What Stock Exchange Does Sprint Bioscience AB (SPRINT) Trade On?
Sprint Bioscience AB is listed and trades on the Stockholm Stock Exchange.
What Is the Ticker (Stock Symbol) for Sprint Bioscience AB?
The stock symbol (also called a 'ticker') for Sprint Bioscience AB is "SPRINT."
What Is the Current Sprint Bioscience AB Market Cap?
As of today, Sprint Bioscience AB market cap is 194.150M SEK.
What Is Sprint Bioscience AB's (SPRINT) Earnings Per Share (TTM)?
The Sprint Bioscience AB EPS is currently 0.980 (Trailing Twelve Months).
When Is the Next Sprint Bioscience AB Earnings Date?
Sprint Bioscience AB's next earnings report will be released on 13/05/2026.
Is SPRINT a Buy or Sell From a Technical Analyst Perspective?
Based on today's Sprint Bioscience AB moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Sprint Bioscience AB Stock Split?
Sprint Bioscience AB has split 2 times. (See the SPRINT stock split history page for full effective split date and price information.)
How Many Employees Does Sprint Bioscience AB Have?
Sprint Bioscience AB has 30 employees.
What is the current trading status of Sprint Bioscience AB (SPRINT)?
As of 09/03/2026, Sprint Bioscience AB (SPRINT) is trading at a price of 1.895 SEK, with a previous close of 1.885 SEK. The stock has fluctuated within a day range of 1.755 SEK to 1.895 SEK, while its 52-week range spans from 0.360 SEK to 2.350 SEK.
What Is Sprint Bioscience AB (SPRINT) Price Target According to Analysts?
The average 12-month price target for Sprint Bioscience AB is 3.300 SEK, with a high estimate of 3.3 SEK and a low estimate of 3.3 SEK. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +74.14% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.